From Our Perspective: OMUFA – Past, Current, and Future

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /> <script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script> <meta name="description" content="The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as the Prescription Drug User Fee Act (PDUFA)." /> <meta name="dcterms.title" content="From Our Perspective: OMUFA – Past, Current, and Future" /> <meta name="dcterms.creator" content="Center for Drug Evaluation and Research" /> <meta name="dcterms.description" content="The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as the Prescription Drug User Fee Act (PDUFA)." /> <meta name="dcterms.publisher" content="FDA" /> <meta name="dcterms.type" content="Article" /> <meta name="dcterms.source" content="FDA" /> <meta property="og:site_name" content="U.S. Food and Drug Administration" /> <meta property="og:type" content="Article" /> <meta property="og:url" content="https://www.fda.gov/drugs/our-perspective/our-perspective-omufa-past-current-and-future" /> <meta property="og:title" content="OMUFA – Past, Current, and Future" /> <meta property="og:description" content="The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as PDUFA." /> <meta property="og:updated_time" content="Tue, 11/19/2024 - 00:00" /> <meta property="article:publisher" content="FDA" /> <meta property="article:published_time" content="Tue, 11/19/2024 - 12:41" /> <meta property="article:modified_time" content="Tue, 11/19/2024 - 00:00" /> <meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="@US_FDA" /> <meta property="twitter:description" content="The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as PDUFA." /> <meta name="twitter:title" content="OMUFA – Past, Current, and Future" /> <meta name="twitter:creator" content="@US_FDA" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "Article", "headline": "From Our Perspective: OMUFA – Past, Current, and Future", "name": "From Our Perspective: OMUFA – Past, Current, and Future", "description": "The OTC Monograph drug user fee program, which we refer to as “OMUFA,” is similar to our other user fee programs, such as the Prescription Drug User Fee Act (PDUFA).", "datePublished": "Tue, 11/19/2024 - 12:41", "dateModified": "Tue, 11/19/2024 - 00:00", "author": { "@type": "Organization", "name": "Center for Drug Evaluation and Research" }, "publisher": { "@type": "Organization", "name": "FDA" } } ] }</script> <meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://www.fda.gov/drugs/our-perspective/our-perspective-omufa-past-current-and-future" /> <link rel="canonical" href="https://www.fda.gov/drugs/our-perspective/our-perspective-omufa-past-current-and-future" /> <link rel="shortlink" href="https://www.fda.gov/node/423944" /> <script src="/files/google_tag/production/google_tag.script.js?smgeuw" defer></script> <title>From Our Perspective: OMUFA – Past, Current, and Future | FDA</title> <link rel="stylesheet" media="all" href="/files/css/css_4qVI3__kNnM159lbX85PiehwLfcQbjhfFGV05vyo-Yg.css?delta=0&language=en&theme=preview&include=eJxlj0FuAzEIRS_khG4q9TYWg7Fj1TYW0ETT0yeTqJMo3SD4SI9HluF4YZPOkJ_9MRSR0jjiwLZ6JYP3INhqzh0WNA5T-Vz5AqXJgu1gvrY6yr-YtE63sIi4ueKEKVPOrCEnjPTNqbpo5HHCQdx5uAESiaYqI7qUTcBOok6SOGxog3s9dkk_jR8c6bPVjfDYxc-Pr5cw5NqcFQin37Ah32SGOBvs3e5Nir8rl-cjCef99N-8yxx2zyuWXoVv" /> <link rel="stylesheet" media="all" href="/files/css/css_xLeUZALg1CD0YmiSIzZnqkwKfNF_g3TkAjkxBt_uccA.css?delta=1&language=en&theme=preview&include=eJxlj0FuAzEIRS_khG4q9TYWg7Fj1TYW0ETT0yeTqJMo3SD4SI9HluF4YZPOkJ_9MRSR0jjiwLZ6JYP3INhqzh0WNA5T-Vz5AqXJgu1gvrY6yr-YtE63sIi4ueKEKVPOrCEnjPTNqbpo5HHCQdx5uAESiaYqI7qUTcBOok6SOGxog3s9dkk_jR8c6bPVjfDYxc-Pr5cw5NqcFQin37Ah32SGOBvs3e5Nir8rl-cjCef99N-8yxx2zyuWXoVv" /> <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script> <script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&subagency=FDA&sdor=fda.gov&dclink=true" language="javascript" id="_fed_an_ua_tag"></script> <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script> </head> <body class="role-anonymous path-node page-node-type-article has-glyphicons"> <div id="quicklinks" class="sr-only"> <ul> <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li> <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li> <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li> <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li> </ul> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="main-container container-fluid"> <div class="row"> <header class="lcds-header container-fluid" role="heading" aria-level="1"> <div class="row us-masthead"> <div class="usa-banner col-xs-12"> <img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" /> <span>An official website of the United States government</span> <a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-controls="USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a> <div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton"> <div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true"> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p> </div> </div> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p> </div> </div> </div> </div> </div> </div> <div class="alert alert-warning margin-left-neg-2 margin-right-neg-2 margin-top-3 margin-bottom-1"> <p>On Oct. 1, 2024, the FDA began implementing a <a href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a> impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.</p> </div> <div class="row fda-masthead"> <div class="col-xs-4 col-md-8"> <a href="/" title="FDA Homepage"> <h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1> </a> </div> <div class="col-xs-8 col-md-4"> <ul class='fda-masthead__item-list'> <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search"> <span class="fa fa-search" aria-hidden="true"> </span> <span class="fda-masthead__btn-label">Search</span> </a></li> <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true"> <span class="fa fa-bars" aria-hidden="true"> </span> <span class='fda-masthead__btn-label'>Menu</span> </a></li> </ul> </div> <form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" > <div class="search-popover" id="search-popover"> <div class="input-group pull-right" id="search-group"> <label class="sr-only" for="search-query">Search FDA</label> <input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text" /> <span class="input-group-btn" id="input-group-btn"> <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button> </span> </div> </div> </form> </div> <nav id="primary-nav" class="lcds-primary-nav row collapse"> <div class="col-md-5 col-lg-4"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Featured</h2> <ul class="lcds-primary-nav__list lcds-primary-nav__list--featured"> <li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li> <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li> <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li> <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li> </ul> </section> </div> <div class="col-md-7 col-lg-8"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Products</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li> <li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li> <li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li> <li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li> <li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li> <li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li> <li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Topics</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li> <li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li> <li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li> <li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li> <li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Information For</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li> <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li> <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li> <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li> <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li> </ul> </section> </div> </nav> </header> <div class="col-xs-12"> <div data-drupal-messages-fallback class="hidden"></div> </div> <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav" >In this section<span class="visible-sm-inline-block">: From Our Perspective </span> </a> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse"> <ul class="lcds-section-nav__list"> <li> <a href="/drugs/news-events-human-drugs/our-perspective" title="From Our Perspective" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link visible-xs-block visible-sm-block"> From Our Perspective </a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-94d40183835f948874d72f75328c43f3c28e8ae739e2009740ea241152225880"> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-73f32a354baddf11bf0ab5bc8bcf0396997266f184c6cec4ecd98b24f89746db"> </div> </div> </li> </ul> </nav> </section> <section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <ol class="lcds-breadcrumb visible-md visible-lg"> <li > <a href="/">Home</a> </li> <li > <a href="/drugs">Drugs</a> </li> <li > <a href="/drugs/news-events-human-drugs">News & Events for Human Drugs</a> </li> <li > <a href="/drugs/news-events-human-drugs/our-perspective">From Our Perspective</a> </li> <li > <a class="current-link">From Our Perspective: OMUFA – Past, Current, and Future</a> </li> </ol> <ol class="lcds-breadcrumb visible-sm visible-xs"> <li> <a href="/drugs/news-events-human-drugs/our-perspective" title="From Our Perspective"> From Our Perspective </a> </li> </ol> </section> <main> <article id="main-content" class="article main-content container-fluid" role="article"> <header class="row content-header" role="heading" aria-level="1"> <section id="block-entityviewcontent-2" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="col-sm-12 col-md-8 col-md-offset-2"> <h1 class="content-title text-center">From Our Perspective: OMUFA – Past, Current, and Future</h1> <div class="lcds-toolbar lcds-toolbar--social"> <ul class="lcds-share lcds-share--default"> <li class="lcds-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.fda.gov%2Fdrugs%2Four-perspective%2Four-perspective-omufa-past-current-and-future" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a> </li> <li class="lcds-share__item"> <a href="https://x.com/intent/tweet/?text=From%20Our%20Perspective%3A%20OMUFA%20%E2%80%93%20Past%2C%20Current%2C%20and%20Future&url=https://www.fda.gov%2Fdrugs%2Four-perspective%2Four-perspective-omufa-past-current-and-future" target="_blank" class="lcds-share__btn lcds-share--default__btn-x-twitter js-share" id="twitter-share"> <svg class="icon-svg-inline" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> Post </a> </li> <li class="lcds-share__item hidden-xs"> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https://www.fda.gov%2Fdrugs%2Four-perspective%2Four-perspective-omufa-past-current-and-future&title=From%20Our%20Perspective%3A%20OMUFA%20%E2%80%93%20Past%2C%20Current%2C%20and%20Future&source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a> </li> <li class="lcds-share__item"> <a href="mailto:?subject=From%20Our%20Perspective%3A%20OMUFA%20%E2%80%93%20Past%2C%20Current%2C%20and%20Future&body=https://www.fda.gov%2Fdrugs%2Four-perspective%2Four-perspective-omufa-past-current-and-future" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a> </li> <li class=" lcds-share__item hidden-xs"> <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a> </li> </ul> <div class="form-group"> </div> </div> </div> </section> </header> <div class="col-md-8 col-md-push-2" role="main"> <p><em>Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research and Theresa Michele, M.D., Director, CDER Office of New Drugs’ Office of Nonprescription Drugs</em></p> <figure class="align-right"> <div alt="Patrizia Cavazzoni, M.D." data-embed-button="media_browser" data-entity-embed-display="media_image" data-entity-embed-display-settings="square_1_1_450_x_450 Array" data-entity-type="media" data-entity-uuid="67bf9e7a-86d4-4144-827c-15846a68a65c" data-langcode="en" title="Patrizia Cavazzoni" class="embedded-entity"> <img loading="lazy" src="/files/styles/square_1_1_450_x_450/public/cavazzoni_patrizia_drupal.png?itok=_WJuHRkT" alt="Patrizia Cavazzoni, M.D." title="Patrizia Cavazzoni" class="img-responsive"> </div> <figcaption class="caption">CDER Director, Patrizia Cavazzoni, M.D.</figcaption> </figure> <p>Over-the-Counter (OTC) drugs have long provided an efficient, low-cost way for Americans to take care of everyday health needs, without having to visit a doctor and obtain a prescription.</p> <p>Most of the OTC drugs sold in the U.S. are monograph drugs. FDA established OTC drug monographs in 1972 as a kind of "recipe book" covering acceptable ingredients, doses, formulations, labeling, and testing for OTC drugs. Products conforming to a monograph may be marketed without FDA pre-approval, while those that do not must undergo separate review and approval through the <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="28f649b1-23c2-4142-b6a1-69e8ecb60f14" href="/drugs/types-applications/new-drug-application-nda" title="New Drug Application (NDA)">New Drug Application</a> (NDA) process. Over time, OTC drug monographs were updated to add new ingredients and labeling as needed. However, until recently, changing monographs required a slow and lengthy rulemaking process which would often take years.</p> <figure class="align-right"> <div alt="Portrait Photo of Theresa Michele" data-embed-button="media_browser" data-entity-embed-display="media_image" data-entity-embed-display-settings="Array" data-entity-type="media" data-entity-uuid="51b000e2-3a28-4f17-aa4a-ac3037ffd5a1" data-langcode="en" title="Portrait Photo of Theresa Michele" class="embedded-entity"> <img loading="lazy" src="/files/MicheleTheresa_900x900_0.png" alt="Portrait Photo of Theresa Michele" title="Portrait Photo of Theresa Michele" class="img-responsive"> </div> <figcaption class="caption">Theresa Michele, M.D.</figcaption> </figure> <p>OTC monograph reform, enacted as part of the 2020 <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="2be45bc4-391d-40c3-ad5e-c79242f9a84d" href="/drugs/over-counter-otc-nonprescription-drugs/over-counter-otc-drug-review-otc-monograph-reform-cares-act" title="Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act">Coronavirus Aid, Relief, and Economic Security Act, also known as the CARES Act</a>, helped increase the efficiency, timeliness, and predictability of OTC monograph drug regulation, and streamlined safety updates. This change was accompanied by providing FDA authority to collect user fees to support OTC monograph drug activities. The OTC Monograph drug user fee program, which we refer to as “<a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="33ec408b-cfd7-4e75-8ad4-be13e6d5fc9b" href="/industry/fda-user-fee-programs/over-counter-monograph-drug-user-fee-program-omufa" title="Over-The-Counter Monograph Drug User Fee Program (OMUFA)">OMUFA</a>,” is similar to our other user fee programs, such as the <a href="/industry/fda-user-fee-programs/prescription-drug-user-fee-amendments#:~:text=The%20Prescription%20Drug%20User%20Fee%20Act%20(PDUFA)%20was%20created%20by,of%20certain%20prescription%20drug%20products.">Prescription Drug User Fee Act (PDUFA)</a>. Under the CARES Act amendments to the <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="559edc18-553a-4bfb-bb73-0bf1ad6c37d3" href="/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act" title="Federal Food, Drug, and Cosmetic Act (FD&C Act)">Federal Food, Drug, and Cosmetic (FD&C) Act</a>, quicker administrative orders replace the long rulemaking process for updating OTC monographs, industry pays fees to help support our regulatory activities related to <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="93350df5-0780-430c-bf66-f4aac8836607" href="/drugs/otc-drug-review-process-otc-drug-monographs" title="OTC Drug Review Process | OTC Drug Monographs">OTC monograph drugs</a>, and FDA agrees to performance goals negotiated with industry. These performance goals include specific time frames for conducting certain OTC monograph activities.</p> <p><em>Administrative Orders</em></p> <p>Sometimes, FDA reviews or receives new data that may demonstrate the need to change a monograph for safety or efficacy reasons. The CARES Act amendments gave us the authority to make these changes to an OTC drug monograph using administrative orders. As FDA issues each proposed or final administrative order, we will publish the order on <a href="https://dps.fda.gov/omuf/ordersearch">OTC Monographs@FDA</a> and in the Federal Register. Publication of proposed orders will be accompanied by an open comment period where the public can weigh in on the proposed change, and we will consider these comments as we develop and issue a final order.</p> <p><em>OMORs</em></p> <p>Either industry or CDER can initiate the administrative order process. A request by industry to initiate the administrative order process is called an <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="69e52521-fcb6-4bc3-b75f-612e05ac3bc6" href="/regulatory-information/search-fda-guidance-documents/over-counter-monograph-order-requests-format-and-content" title="Over-the-Counter Monograph Order Requests: Format and Content">OTC Monograph Order Request (OMOR)</a> and can be made by a requestor, which is any person or group of persons marketing, manufacturing, processing, or developing a drug. Before submitting an OMOR, FDA recommends the requestor meet with us to discuss specific data, studies, and related information that will be submitted in the OMOR.</p> <p>FDA has the authority to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and requestors of OMORs to support the agency’s OTC monograph drug activities. There is an exception to this fee collection when the OMOR is to update the OTC monograph with certain safety changes.</p> <p><em>OMUFA I Accomplishments</em></p> <p>OTC monograph reform has benefitted patients, industry, and our nation’s health care system and has reduced regulatory burden. During the first years of the program, FDA has successfully created much of the infrastructure necessary to achieve these benefits, such as:</p> <ul> <li>Creating a new IT system, <a href="https://dps.fda.gov/omuf">OTC Monographs@FDA</a>, which maintains relevant documents related to the monographs.</li> <li>Posting an <a href="https://dps.fda.gov/omuf/forecast">annual monograph forecast</a> each year, which is a nonbinding list of the of planned monograph activities that FDA intends to initiate over the next three years.</li> <li>Posting all 33 OTC monograph final orders deemed established by law upon enactment of OTC monograph reform, which set forth conditions under which OTC monograph drugs in certain therapeutic categories are generally recognized as safe and effective (GRASE).</li> <li>Meeting all performance goals for formal meetings between FDA and industry.</li> <li>Expanding the <a href="https://cdernextgenportal.fda.gov/Login_CDER?ec=302&startURL=%2Fs%2F">CDER NextGen Portal</a> to enable certain electronic OTC monograph submissions.</li> <li>Issuing five draft guidances.</li> <li>Finalizing the guidance, “<a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="deb5ff64-2ed2-4855-90b8-b0d8bcf2ff6e" href="/regulatory-information/search-fda-guidance-documents/providing-over-counter-monograph-submissions-electronic-format" title="Providing Over-the-Counter Monograph Submissions in Electronic Format">Providing Over-the-Counter Monograph Submissions in Electronic Format</a>.”</li> </ul> <p>In addition, FDA published two proposed orders - the first was an FDA-initiated proposed order to address a safety issue related to OTC monograph drug products containing acetaminophen. This <a href="https://dps.fda.gov/omuf/ordersearch/order_otc000035">proposed order</a>, if finalized, would require drug companies to add a warning to the labeling of these products to alert consumers that the use of acetaminophen may cause severe skin reactions. The second proposed order was an FDA-initiated order to amend the relevant OTC monograph to remove oral phenylephrine as an active ingredient for the temporary relief of nasal congestion because it is not effective. Before making the decisions to issue this proposed order, we held an advisory committee meeting on this issue and informed the public of our intent to publish this order in the annual monograph forecast. We also published a proposed order to amend the sunscreen monograph, as was required by the CARES Act.</p> <p><em>OMUFA II Negotiations </em></p> <p>The current legislative authority for OMUFA expires September 30, 2025. At that time, Congress will have to reauthorize the OMUFA program in order to continue the program for future fiscal years. As it does for several other user fee programs, FDA is required by law to engage in negotiations with industry to develop recommendations to reauthorize OMUFA for fiscal years 2026 through 2030, i.e., OMUFA II. As part of the reauthorization process, FDA held a public meeting on September 28, 2023, to obtain the perspective of scientific and academic experts, health care professionals, patients, consumers, and regulated industry on OMUFA reauthorization. FDA will host a second and final public meeting on November 20, 2024, to solicit feedback on the <a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="fa9b304f-bb10-4e22-901d-614370a56c0f" href="/media/182750/download?attachment" title="Over-the-Counter Monograph Drug User Fee Program Performance Goals and Procedures—Fiscal Years 2026-2030">OMUFA II commitment letter</a> (a document that generally outlines goals and timeframes agreed to by FDA and industry for specified OTC monograph drug activities), as well as other elements of the OMUFA reauthorization recommendations. We <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="96236b6b-d18a-46e4-b407-f00f28817255" href="/drugs/news-events-human-drugs/public-meeting-recommendations-over-counter-monograph-drug-user-fee-program-omufa-reauthorization" title="Public Meeting on the Recommendations for the Over-the-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization - 11/20/2024 - 11/20/2024">invite public comment</a> on the OMUFA reauthorization recommendations, through a docket (<a href="https://www.federalregister.gov/documents/2024/11/01/2024-25458/reauthorization-of-the-over-the-counter-monograph-drug-user-fee-program-public-meeting-request-for">FDA-2023-N-3575</a>) open until December 20, 2024.</p> <h2>Additional Information</h2> <ul> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="d395f443-19ec-4aae-880f-6362d68a639a" href="/regulatory-information/search-fda-guidance-documents/formal-dispute-resolution-and-administrative-hearings-final-administrative-orders-under-section-505g" title="Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act">Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Food, Drug, and Cosmetic Act</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="69e52521-fcb6-4bc3-b75f-612e05ac3bc6" href="/regulatory-information/search-fda-guidance-documents/over-counter-monograph-order-requests-format-and-content" title="Over-the-Counter Monograph Order Requests: Format and Content">Over-the-Counter Monograph Order Requests (OMORs): Format and Content</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="8b2fea9c-3e14-4653-bfe8-826376c2541c" href="/regulatory-information/search-fda-guidance-documents/assessing-user-fees-under-over-counter-monograph-drug-user-fee-program" title="Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program">Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="deb5ff64-2ed2-4855-90b8-b0d8bcf2ff6e" href="/regulatory-information/search-fda-guidance-documents/providing-over-counter-monograph-submissions-electronic-format" title="Providing Over-the-Counter Monograph Submissions in Electronic Format">Providing Over-the-Counter Monograph Submissions in Electronic Format</a></li> <li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="4978eaae-c149-4b1f-9a90-999029427eab" href="/regulatory-information/search-fda-guidance-documents/formal-meetings-between-food-and-drug-administration-and-sponsors-or-requestors-over-counter" title="Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs">Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs</a></li> </ul>   </div> <aside class="col-md-2 col-md-push-2" role="complementary"> <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <aside class="lcds-card lcds-card--border-top"> <ul role="menu" class="lcds-description-list"> <li role="menuitem" class="node-current-date lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Content current as of:</h2> <p class="lcds-description-list__item-text"><time datetime="2024-11-19T00:00:00Z">11/19/2024</time> </p> </div> </li> <li role="menuitem" class="lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2> <ul role="menu" class="lcds-metadata-list"> <li role="menuitem">Drugs</li> </ul> </div> </li> </ul> </aside> </div> </section> </aside> <aside class="col-md-2 col-md-pull-10" role="complementary"> <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <nav id="section-nav"class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm"> <ul class="lcds-section-nav__list lcds-section-nav--side__list"> <li> <a href="/drugs/news-events-human-drugs/our-perspective" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link"> From Our Perspective </a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-d3a37543767c93f82d4c0437568299fac2c6ff55a88c1567a91020355ba5fc9f"> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_1 js-view-dom-id-d86a8cb073801338cd60738f25cd6a4297602e65bd1be03b41e822e4df2a39a2"> </div> </div> </li> </ul> </nav> </div> </section> </aside> </article> </main> </div> </div> <div class="region region-subscribe"> <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> </section> </div> <footer class="lcds-footer container-fluid"> <div class="row lcds-footer__primary"> <h2 id="footer-heading" class="sr-only">Footer Links</h2> <nav class="text-center"> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li> <li><a href="/about-fda" >About FDA</a></li> <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li> <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li> <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li> <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li> <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li> <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li> </ul> </div> </nav> </div> <div class="row lcds-footer__secondary"> <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links"> <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a> <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> <span class="fa fa-facebook fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Facebook</span> </span> </a> <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer"> <svg class="icon-svg-inline fa-2x" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> <span class="sr-only">Follow FDA on X</span> </a> <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer"> <span class="fa fa-instagram fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Instagram</span> </span> </a> <br class='visible-xs-inline'/> <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer"> <span class="fa fa-linkedin fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on LinkedIn</span> </span> </a> <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer"> <span class="fa fa-youtube fa-2x" aria-hidden="true"> <span class="sr-only">View FDA videos on YouTube</span> </span> </a> <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds"> <span class="fa fa-rss fa-2x" aria-hidden="true"> <span class="sr-only">Subscribe to FDA RSS feeds</span> </span> </a> </div> <a href="/" title="FDA Homepage"> <div class="visible-lg-block col-lg-4 text-center lcds-footer__logo"> <span class="sr-only">FDA Homepage</span> </div> </a> <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number"> <span class="fa fa-phone" aria-hidden="true"> </span> <span class="sr-only">Contact Number</span> 1-888-INFO-FDA (1-888-463-6332) </div> </div>  </footer> <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/423944","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"utm_medium":"email","utm_source":"govdelivery"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"3aef67b4ac7d861d8624bf1f7ab2bc9cfc56d3c25b7d709dc15466dfa996dfb0"}}</script> <script src="/files/js/js_jmx6639WuKcEs1DgFSmm8g__5ByGF4YtLnPWvZO-XrM.js?scope=footer&delta=0&language=en&theme=preview&include=eJxlj0FuAzEIRS_khG4q9TYWg7Fj1TYW0ETT0yeTqJMo3SD4SI9HluF4YZPOkJ_9MRSR0jjiwLZ6JYP3INhqzh0WNA5T-Vz5AqXJgu1gvrY6yr-YtE63sIi4ueKEKVPOrCEnjPTNqbpo5HHCQdx5uAESiaYqI7qUTcBOok6SOGxog3s9dkk_jR8c6bPVjfDYxc-Pr5cw5NqcFQin37Ah32SGOBvs3e5Nir8rl-cjCef99N-8yxx2zyuWXoVv"></script> <script type="text/javascript" src="/Glj4GCbp15rt1JYQ1bjdCY17/OOpiQpwDbfwtpO1S/LygGdz4/IiljWE0/wM2Y"></script></body> </html>

CINXE.COM

From Our Perspective: OMUFA – Past, Current, and Future | FDA